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stereochemistry of the nucleoside derivatives was confirmed on the basis of 1D NOE difference spectroscopy and is discussed in detail below.
Structural assignment of triqc& cis-fused 2'-and 3'-spim-isoxa&idine nuckosides 10 and 13
The saturation of H7 ' (Fig. 1 [panel A2]) in c&fused 3'-Spiro-isoxazolidine 10 shows enhancements at Hl' (0.4%). H4' (4.3%), H13' (2.4%), H13" (0.3%) and H8' (1.2%) which prove C2'(R), C3'(S), C7(S)
configurations, whereas saturation of NMe in 10 (Fig. 1 [panel Al]) gives key enhancement at H2' (2.5%) which proves NlO(S) configuration. The orientation of thymine base is anti which was clear from the results of saturation at Hl' and H2' giving 0.3% andl.6% NOE enhancements at H6, respectively. The saturation of Hl'
in &fused 2'-Spiro-isoxazolidine 13 ( Fig. 1 [panel BZ]) shows key NOE enhancement at H7' (3.5%) which proves that cyclization underwent on the a-face of pentofuranosyl moiety and C2'(S), C3'(S), C7(R)
configurations. The NOE enhancements at H3' (1.5%) and H8" (0.3%) upon saturation of NMe ( Fig. 1 [panel Bl]) in 13 R rove NlO(R) configuration.
Synt esis of trkyclic ck-jbeed-silicon-tethered-2'-and 3'-Spiro-koxazolidine nuckosides 20 and 29
While it was clear from the above described work that the intramolecular 1.3~dipolar cyclisation affords products with high regio and stereoselectivity, the procedure is of limited utility unless it is applicable to the synthesis of nucleosides bearing a free hydroxyl group at the C4(7) position of the Spiro moiety and at the 2'-or 3'-positions of the furanose moiety. The availability of these 1,3dihydroxy derivatives will clearly pave the way for specific deoxygenation or further functionalization at either of these centres, thus enabling structure-activity studies against HIV reverse transcriptase to be carried out. Consequently, the introduction of the silyl-tethered alkene was investigated.
1-(S-0-MMTr-P-D-&~furanosyl)thymine~ (14), when treated with tert-butyldimethylsilylchloride and imidazole under the reaction conditions described by Matsuda and coworkers,t2 afforded a 3:4 mixture of the 3'-and 2'-0-TBDMS-protected nucleosides 15 (33%) and 24 (42%), respectively, which were separated by column chromatography (Scheme 2). Recycling of the 2'-0-TBDMS-protected derivative 24 to prepare additional 3'-0-TBDMS-protected derivative 15 was possible by partial isomerization affected by heating the 2'-0-TBDMS-derivative 24 in methanol for several hours at reflux.13
Both 3'-and 2'-0-TBDMS protected nucleoside derivatives 15 and 24, respectively, were oxidized under similar conditions to those described for nucleosides 2 and 3. The reaction of 15 and 24 with the chromium trioxide/pyridine/acetic anhydride reagent gave the corresponding 2'-and 3'ulosides 16 and 25 respectively.
These were in turn separately treated with iV-methylhydroxylamine hydrochloride in pyridine to afford the corresponding 2'-and 3'-N-methylnitrones 17 (67%) and 26 (69%). Removal of the 3'-or 2'-0-TBDMS group by the treatment of a methanolic solution of the nucleoside derivative 17 or 26 with ammoniun fluoride at 0°C
for 6 h afforded the 2'-or 3'-N-methylnitrones 18 (67%) and 27 (84%), respectively. It was essential that the reaction be carried out at low temperature and with the exclusion of moisture for an optimal yield of the Nmethylnitrones. The assignment of the configuration of N-methylnitrone 27 was on the basis of 1D NOE difference spectroscopy. The saturation of NMe group in 27 shows a key NOE enhancement at H2' (0.4%) which proves the (Z)-configuration along the nitrone double bond. Assignment of the configuration of Nmethylnitrone 17 was not possible owing to the broadness of Hl' and H3' peaks7h.c in the 1D proton spectrum and the almost isochronous chemical shifts of the NMe and OMe groups (A6 = 0.06 ppm).
2'-or 3'-N-methylnitrone 18 or 27 was then dissolved in dry pyridine and treated with one equivalent of vinyldimethylchlorosilane to give the intermediary vinylsilanes 19 and 28 which underwent tandem [3 +2] cycloaddition with the vicinal N-methylnitrones. The reaction mixture was maintained at 0°C for 1 h before 2'-And 3'-hypemodified tricyclic nucleosides 4925 being allowed to warm slowly to room temperature. The sole product isolated from the reaction mixture after 6 h at room temperature was the tricyclic adduct 29 (70%) or 29 (75%), respectively. The stemchemical and the structural assignment of each isomer was on the basis of its NMR spectral properties and 1D NOE difference spectroscopy and is discussed in detail below.
The hydrogen peroxide mediated Tamao Oxidation10 was used to oxidatively cleave the silylheterocycle of 243 or 29 in a stereospecific manner to afford the respective 1,3-diols 21 (91%) or 30 (64%). The retention of the stereochemical integrity of the isoxazolidines 21 and 30 is consistent with the findings of Tamao and coworkers that the oxidative cleavage takes place with retention of stereochemistry. This fact was confirmed by 1D NOE difference spectroscopy. To our knowledge, this constitutes the first time that the Tamao reaction has been performed in concert with the 1,3-dipolar cyclisation reaction to generate 1,3-dihydroxy isoxazolidine The regiochemical outcome of the cycloaddition reaction is consistent with the findings of Baldwin et al.14 Their study concentrated on the intramolecular cycloaddition of 5-alkenyl nitrones, in which the sole product isolated from the intramolecular cycloaddition of unsubstituted alkenes were the &-fused adducts. Based on the configuration of the starting N-methylnitrone 27 (i.e. (Z)) and the orientation of the N-methyl group in the isoxazolidine 29, it is possible to draw some conclusions on the transition state geometry. Clearly, the &-fused isoxazolidine 29, which is consistent with our 1D NOE difference spectroscopy (vide infra), results from the interaction of the terminal carbon of the alkene with the oxygen atom of the nitrone and interaction between the Co-carbon of the alkene and C3' of the nitrone. The stereochemistry of the final product 29 suggests that the cycloaddition proceeds exclusively through an en&transition state,15 with the Nmethyl group adopting a relative cisoid orientation towards both H2' and C4(7) substituent in both the reactant 27 and the product 29. The cycloaddition of putative 19 to adduct 20 also similarly suggests the involvement ofendo-transition state.
The saturation of H7' in 21 shows key NOE enhancement at HI' (4.8%), H8' (1.5%). H8" (0.3%), whereas saturation of NMe shows enhancement at H3' (2.5%) and HS" (0.5%) which prove C2'(S), C3'(S), C7(S) and NlO(R) configuration. The saturation of H7' in 30 shows key NOE enhancements at Hl' (0.9%). H4
(4.3%), H8' (0.2%), H8" (2.3%), whereas saturation of NMe gives NOE enhancement at H2' (2.9%). HS' (0.9%) and H6 (0.3%) which prove C2'(R), C3'(R), C7(R), NlO(S) configurations.
Conformation of tricyclic nucleoside derivatives 10,13,20 and 29. The 3JBB measured at 500 MHz were translated into corresponding proton-proton torsion angles (QBB) with 2'-And 3'-hypemodified tricyclic nucleosides MHz using both IH-coupled and lH-decoupled modes. Chemical shifts are quoted as 6 in parts per million. Multiplicities ate abbreviated to: s, singlet; d, doublet; t, triplet; q. quartet; m, multiplet; br, broad. A Jeol DX 303 spectrometer was used to record high resolution mass spectra. T.1.c. was carried out using Merck pre-coated silica gel F254 plates. Column chromatographic separations were carried out on Merck G60 silica gel using a gradient of methanol and dichloromethane. All solvents were distilled before use. Drying and purification of all solvents and reagents was accomplished by standard laboratory procedures?l 1-(5'-0-MMTr-2'-0-allyl-P_D-xyloluranosyl)thymine (2) a n d l-(5'-O-MMTr-3'-O-allyl-B-D_ ambinofuranusyl)thymine (3) Sodium hydride (0.11 g, 4.5 mmol) was added slowly to a stirred solution of ally1 alcohol (5 ml) maintained at 0-K and allowed to stir for a further 15 mins. A solution of l-(5'-O-MMTr-2',3'-O-anhydro-P-D-lyxofuranosyl)thymine9 (1) (0.77 g, 1.5 mmol) in ally1 alcohol (3 ml) was then added and the resulting solution was sonicated for 72 h at room temperature. The reaction was quenched by the slow addition of saturated aqueous NH&l to the mixture. Concentration of the reaction mixture to remove ally1 alcohol followed by extraction of the aqueous phase with dichloromethane afforded a 2:3 mixture of the title compounds 2 and 3 as a foam, which was subsequently chromatographed on silica gel to give compound 2 (245 mg, 30%) and compound 3 (380 mg, 44%) as colourless foams. Compound 2: tH NMR (CDCls) 9.04 (br s, 1H) NH; 7.59 (q, 56 5Me = 1.1 Hz) H6; 7. 45-6.84 (m, 14H) (2) 3',5'-O-isopropylidene-P_D-5-methyluridine (4) (1.0 g, 3.4 mmol) was dissolved in THF and treated with sodium hydride (80% in psrrafin oil) (0.3 g, 10 mmol). The resulting solution was stirred vigorously at room temperature for 15 minutes before a THF solution of ally1 bromide (1.2 g, 10 mmol) was added in a dropwise fashion. The resulting mixture was stirred at room temperature for 7 h. The reaction was quenched by the addition of saturated ammonium chloride and then partitioned with dichloromethane. The organic phase was concentrated and the residue chromatographed on silica gel to afford 3',5'-0-isopropylidene-2'-O-allyl-P_D-5-methyluridine (5 derivative 5 (320 mg, 1.0 mmol) was dissolved in 80% AcOH/H20 and stirred at room temperature overnight. The solution was concentrated under reduced pressure to give an oil which was chromatographed on silica gel to afford 2'-0-allyl-P-D-5-methylutidine (280 g, 97%) as a colourless oil. This oil was dissolved in pyridine (4 ml) and then treated with MMTrCl (400 mg, 1.3 mmol). The solution was stirred at room temperature overnight. The resulting yellow solution was poured into ice water and allowed to stir for several minutes. The suspension was then extracted with dichloromethane and the organic layer concentrated to give an oil which was chromatographed on silica gel to yield compound 2 (460 mg, 83%) as a colourless foam. This compound 2'-And 3'-hypennodified tricyclic nucleosides 4931 had spectral characteristics consistent with those reported above. 8 mmol) and imidazole (0.64 g. 9.4 mmol) in dimethylformamide (4 ml). The mixture was stirred overnight at room temperature. The resulting mixture was poured into ice water and extracted with dichloromethane. The organic layer was concentrated under reduced pressure to yield an oil which consisted of three components. These components wete separated by chromatography on silica. 1-(5'-0-MMTr-2',3'-bis-O-TBDMS-j3-D-ribofuranosyl)thymine was isolated in 12 96 yield while compound 15 was isolated in 33 8 and compound 24 was isolated in 42 % yield. The isolated 2'GTBDMS protected derivative 24 was then dissolved in methanol and refluxed for 3 h. ; 158.4; 149.7 and 146.9 (2 x (s)) C4 and C2'; 143.7; 139.6 (br d, JCH = 176.3 Hz) C6; 134.9; 130.1; 128.2; 127.5; 126.7; 112.8 (22) Spiro-nucleoside derivative 21(20 mg, 0.03 mmol) was co-evaporated with dry pyridine twice, redissolved in dry pyridine (2 ml) and then treated with acetic anhydride (100 ~1, 1 mmol) at room temperature overnight. Pyridine was then removed under vacuum, the residue dissolved in 20 ml dichloromethane, washed with saturated aq. sodium bicarbonate solution and water, then evaporated to dryness. Residual pyridine was removed by coevaporating with toluene and dichloromethane. The concentrate was purified by preperative TLC to afford the diacetate 22 (12 mg, 58%). rH NMR (CDCl3) 7.69 (br s, 1H) NH; 7.47-6.84 (m, 15H) arom. and H6; 6.26 (s, 1H) Hl'; 5.92 (dd, .I7 s-= 2.8 Hz and JT 8' = 6.1 HZ, 1H) H7'; 5.75 (s, 1H) H3'; 4.19 (dd, 54 5' = 6.5 Hz and JJ,~" = 8.4 Hz, 1H) H4'; 4.10 (dd, 5s 8" = 'lo.0 HZ, 1H) H8'; 3.80 (s, 3H) OMe; 3.77 (dd, 1H) k8"; 3.53 (dd, J 5',~= 10.0 Hz, 1H) H5'; 3.16 (dd, 1H) k5'*; 2.41 (s, 3H) NMe; 2.13 (s, 3H) GOMe; 2.03 (s, 3H) COMe; 2.03 (s, 3H) 5Me. *sC NMR (CDCl3) 168.9 (s) COMe; 168.5 (s) GOMe; 163.3 (s) C2; 158.8 (s); 150.5 (s) C4; 143.5; 137.0 (d, JCR = 185.8 Hz) C6; 134.9; 130.1; 128.3; 127.9; 127.2 
